| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |